Effects of Dapagliflozin Compared With Glimepiride on Body Composition in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms BEYOND
- Sponsors AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 28 Apr 2017 Planned End Date changed from 1 Apr 2018 to 23 Jan 2018.
- 28 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 23 Jan 2018.